Christopher Jonkergouw

Co-founder and CEO at Arivin therapeutics

Speaker

Promising science often fails to reach patients. To change this, I co-founded Arivin therapeutics together with three experienced biotech PhDs, where I serve as CEO. Our goal is to advance novel therapies against the most problematic and resistant bacterial infections. I hold an MSc (Edinburgh) and a PhD (Aalto, best thesis award), with research experience at Stanford University’s Division of Pulmonary Medicine, combining deep scientific expertise with commercial drive.